Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TE vs GSK✓SelectedUSD · GSKTE vs GSK performance historyLatest closeAs of-10.74%11/17
Stock and ETF performance explorer

TE vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-90.3%
GSK return
+43.9%
Excess return
-134.2%
Maximum drawdown
-94.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-10.7%-2.3%-8.4%-10.7%
7D-35.7%-3.0%-32.7%-35.7%
30D-49.2%+0.4%-49.6%-49.2%
3M-72.7%-1.2%-71.6%-72.7%
6M-76.5%+0.9%-77.5%-76.6%
YTD-80.1%+4.0%-84.1%-80.4%
1Y-58.2%+7.3%-65.5%-59.1%
3Y-16.9%+57.1%-73.9%-25.6%
5Y-90.3%+43.0%-133.3%-93.5%
All-90.3%+43.9%-134.2%-93.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling